BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

814 related articles for article (PubMed ID: 23521696)

  • 21. Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.
    Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Syrjänen K
    Virchows Arch; 2009 Dec; 455(6):505-15. PubMed ID: 19908064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk human papilloma virus management in pregnancy with cervical intraepithelial neoplasia during pregnancy and postpartum in China.
    He Y; Wu YM; Zhao Q; Wang T; Song F; Zhu L
    J Obstet Gynaecol Res; 2014 Feb; 40(2):538-44. PubMed ID: 24125014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K; Yoshikawa H; Yasugi T; Nakagawa S; Kawana K; Takeoka A; Yaegashi N; Iwasaka T; Kanazawa K; Taketani Y; Kanda T
    J Med Virol; 2003 Mar; 69(3):441-6. PubMed ID: 12526056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.
    Kojima S; Kawana K; Fujii T; Yokoyama T; Miura S; Tomio K; Tomio A; Yamashita A; Adachi K; Sato H; Nagamatsu T; Schust DJ; Kozuma S; Taketani Y
    Am J Reprod Immunol; 2011 Nov; 66(5):435-43. PubMed ID: 21749545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of human papillomavirus type 16-specific immunologic responses in a normal and an human papillomavirus-infected populations.
    Cheng WF; Lee CN; Su YN; Chang MC; Hsiao WC; Chen CA; Hsieh CY
    Immunology; 2005 May; 115(1):136-49. PubMed ID: 15819706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa.
    Marais D; Rose RC; Williamson AL
    J Med Virol; 1997 Feb; 51(2):126-31. PubMed ID: 9021543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of cervical regulatory T cells in HPV-related cervical intraepithelial neoplasia (CIN) correlates inversely with spontaneous regression of CIN.
    Kojima S; Kawana K; Tomio K; Yamashita A; Taguchi A; Miura S; Adachi K; Nagamatsu T; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Wada-Hiraike O; Yano T; Taketani Y; Fujii T; Schust DJ; Kozuma S
    Am J Reprod Immunol; 2013 Feb; 69(2):134-41. PubMed ID: 23057776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.
    Iwata T; Fujii T; Morii K; Saito M; Sugiyama J; Nishio H; Morisada T; Tanaka K; Yaguchi T; Kawakami Y; Aoki D
    Int J Clin Oncol; 2015 Feb; 20(1):126-33. PubMed ID: 24578180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of p16
    Badiga S; Chambers MM; Huh W; Eltoum IA; Piyathilake CJ
    Cancer; 2016 Dec; 122(23):3615-3623. PubMed ID: 27479745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local expression of interferon-alpha and interferon receptors in cervical intraepithelial neoplasia.
    Tirone NR; Peghini BC; Barcelos AC; Murta EF; Michelin MA
    Cancer Immunol Immunother; 2009 Dec; 58(12):2003-10. PubMed ID: 19381629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
    Einstein MH; Studentsov YY; Ho GY; Fazzari M; Marks M; Kadish AS; Goldberg GL; Runowicz CD; Burk RD
    Int J Cancer; 2007 Jan; 120(1):55-9. PubMed ID: 17036320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasia.
    Syrjänen S; Naud P; Sarian L; Derchain S; Roteli-Martins C; Tatti S; Branca M; Erzen M; Hammes LS; Costa S; Longatto-Filho A; Syrjänen K
    Am J Clin Pathol; 2010 Jul; 134(1):50-9. PubMed ID: 20551266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.
    Bontkes HJ; de Gruijl TD; van den Muysenberg AJ; Verheijen RH; Stukart MJ; Meijer CJ; Scheper RJ; Stacey SN; Duggan-Keen MF; Stern PL; Man S; Borysiewicz LK; Walboomers JM
    Int J Cancer; 2000 Oct; 88(1):92-8. PubMed ID: 10962445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers.
    Mezache L; Paniccia B; Nyinawabera A; Nuovo GJ
    Mod Pathol; 2015 Dec; 28(12):1594-602. PubMed ID: 26403783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
    Gill DK; Bible JM; Biswas C; Kell B; Best JM; Punchard NA; Cason J
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
    Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
    Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia].
    Zhao FH; Hu SY; Wang SM; Chen F; Zhang X; Zhang WH; Pan QJ; Qiao YL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul; 43(7):565-70. PubMed ID: 19954065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.